The article discusses a first-of-its-kind study in France on the use of psychedelic medicine to treat mental illnesses. The study, led by researchers at the French National Institute of Health and Medical Research (INSERM), will focus on the use of psilocybin, a psychedelic substance found in certain mushrooms, to treat depression and anxiety in patients who have not responded to traditional treatments. The study will involve 30 patients and will take place at the psychiatric hospital of the University of Paris. The researchers hope that the study will provide a better understanding of the therapeutic potential of psychedelic substances and their ability to help patients with treatment-resistant mental illnesses.
In summary, the article mentions a new study in France that will use psychedelic medicine, specifically psilocybin, to treat depression and anxiety in patients who have not responded to traditional treatments.